298.40CHF-1.52%Mkt Cap: —P/E: 21.01Last update: 2026-05-13
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Del…
Industry Peers
Medical Instruments & Suppliesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)21.01
P/E (Forward)22.76
PEG4.22
P/B5.01
P/S5.14
EV/EBITDA13.73
EV/Revenue5.11
EPS (TTM)14.21
EPS (Forward)13.03
Cash Flow & Leverage
FCF Yield—
FCF Margin-6.45%
Operating CF148.20M CHF
CapEx (TTM)277.15M CHF
Net Debt/EBITDA-0.09
Net Debt-26.30M CHF
Technical
SMA 50284.48 (+4.9%)
SMA 200324.62 (-8.1%)
Beta0.74
S&P 52W Chg24.23%
Avg Vol (30d)19.09K
Avg Vol (10d)20.97K
Technical Indicators
RSI (14)57.8
MACD2.9668
MACD Signal0.6819
MACD Hist.+2.2849
BB Upper305.82 CHF
BB Middle287.51 CHF
BB Lower269.20 CHF
BB Width12.74%
ATR (14)9.597 CHF
Vol Ratio (20d)1.44x
52W Range
260.5021% of range441.50
52W High441.50 CHF
52W Low260.50 CHF
Profitability
Gross Margin39.00%
EBITDA Margin37.19%
Profit Margin11.68%
Oper. Margin46.11%
ROE12.87%
ROA6.58%
Revenue Growth11.90%
Earnings Growth326.40%
Balance Sheet
Debt/Equity0.39
Current Ratio1.47
Quick Ratio0.75
Book Value/Sh59.15 CHF
Cash/Share2.660 CHF
Dividends
Fwd Div Rate2.200 CHF
Trail. Div Rate2.200 CHF
Div. Yield0.74%
5Y Avg Yield0.53%
Payout Ratio15.48%
Ex-Div DateJul 4, 2025
Pay DateJul 3, 2024
Ownership
Shares Out.13.65M
Float4.01M
Insiders70.54%
Institutions15.72%
Analyst Consensus
Rating1.5 (Strong Buy)
Target (Mean)387.82 CHF
Target Range330.00 CHF – 440.00 CHF
# Analysts11
Company
Market Cap—
Enterprise Value4.02B CHF
Revenue (TTM)787.55M CHF
Gross Profit292.07M CHF
Net Income (TTM)87.50M CHF
Revenue/Share57.71 CHF
Fiscal Year EndMar 2025
MR QuarterSep 2025
Employees2.0K
Last Price298.40 CHF
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0019396990